# Cost- Effectiveness and Quality of Life Assessment in Mood Disorder

> **NCT02870283** · PHASE4 · COMPLETED · sponsor: **Federal University of Rio Grande do Sul** · enrollment: 107 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Lithium
- **DRUG:** Valproic Acid
- **DRUG:** Carbamazepine

## Key facts

- **NCT ID:** NCT02870283
- **Lead sponsor:** Federal University of Rio Grande do Sul
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2014-11
- **Final completion:** 2015-09
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02870283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02870283, "Cost- Effectiveness and Quality of Life Assessment in Mood Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02870283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*